A randomized phase III trial of four cisplatin containing doublet combinations in stage IV B, recurrent or persistent cervical cancer: a Gynecologic Oncology Group (GOG) study. - Monk, B J; Sill, M; McMeekin, D S (J Clin Oncol, 2008)
et al